Update on SCIB2 clinical development partnership Do download click here Wednesday 3 February 2021 09:45 Categories: Immunobody News Regulatory News SCIB2 Year - 2021
Scancell Interim Results To download click here Friday 31 January 2020 10:00 Categories: AvidiMab Modi-1 Moditope News Regulatory News SCIB1 SCIB2 Year - 2020
Scancell exploring new frontiers in cancer research Here we take a closer look at Scancell, which is at the vanguard of immuno-oncology [View article] Monday 20 May 2019 14:51 Categories: Media Coverage Modi-1 SCIB1 SCIB2 Year - 2019
Scancell and Cancer Research UK provide an update on the development of SCIB2, a novel cancer immunotherapy To download click here. Monday 20 May 2019 13:00 Categories: News Regulatory News SCIB2 Year - 2019
Scancell surges after announcing milestone in development of its solid tumours treatment Scancell has a clinical development partnership with Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research [View article] Monday 20 May 2019 11:23 Categories: Immunobody Media Coverage SCIB2 Year - 2019
Scancell Holdings wins Japanese patent protection It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia [View article] Monday 8 April 2019 13:20 Categories: Immunobody Media Coverage SCIB1 SCIB2 Year - 2019
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise [View article] Tuesday 12 February 2019 20:07 Categories: Immunobody Media Coverage Modi-1 Modi-2 SCIB1 SCIB2 Year - 2019
Scancell hires two industry veterans as it gears up for the next development phase The company has brought in outside research and manufacturing expertise. [View article] Monday 21 January 2019 12:29 Categories: Media Coverage SCIB1 SCIB2 Year - 2019
Scancell Holdings part of the new cancer revolution The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology. [View article] Tuesday 25 September 2018 13:20 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 SCIB2 Year - 2018
Proposed Placing, Subscription and Open Offer To download click here Wednesday 18 April 2018 13:00 Categories: Modi-1 News Regulatory News SCIB1 SCIB2 Year - 2018